[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ID27031A - Komposisi farmasi bersalut enterik dan metode pembuatannya - Google Patents

Komposisi farmasi bersalut enterik dan metode pembuatannya

Info

Publication number
ID27031A
ID27031A IDW20002395A ID20002395A ID27031A ID 27031 A ID27031 A ID 27031A ID W20002395 A IDW20002395 A ID W20002395A ID 20002395 A ID20002395 A ID 20002395A ID 27031 A ID27031 A ID 27031A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical
composition
manufacture method
enteric
enteric pharmaceutical
Prior art date
Application number
IDW20002395A
Other languages
English (en)
Inventor
Ismat Ullah
Gary J Wiley
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22179393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID27031(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ID27031A publication Critical patent/ID27031A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20002395A 1998-05-22 1998-08-04 Komposisi farmasi bersalut enterik dan metode pembuatannya ID27031A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8359798A 1998-05-22 1998-05-22

Publications (1)

Publication Number Publication Date
ID27031A true ID27031A (id) 2001-02-22

Family

ID=22179393

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002395A ID27031A (id) 1998-05-22 1998-08-04 Komposisi farmasi bersalut enterik dan metode pembuatannya

Country Status (40)

Country Link
US (2) US6224910B1 (id)
EP (1) EP1079809B1 (id)
JP (2) JP3798625B2 (id)
KR (1) KR100484299B1 (id)
CN (1) CN1149075C (id)
AP (1) AP1206A (id)
AR (1) AR017747A1 (id)
AT (2) ATE311859T1 (id)
AU (1) AU750911B2 (id)
BG (1) BG65398B1 (id)
BR (1) BR9815861A (id)
CA (1) CA2332922C (id)
CO (1) CO5070679A1 (id)
CY (1) CY1119543T1 (id)
CZ (1) CZ300497B6 (id)
DE (2) DE69832731T2 (id)
DK (2) DK1079809T3 (id)
DZ (1) DZ2797A1 (id)
EE (1) EE04926B1 (id)
ES (1) ES2165833T3 (id)
GE (1) GEP20033014B (id)
HK (1) HK1034461A1 (id)
HU (1) HU226491B1 (id)
ID (1) ID27031A (id)
IL (1) IL139274A (id)
LT (1) LT4843B (id)
LV (1) LV12602B (id)
MA (1) MA26636A1 (id)
NO (2) NO322903B1 (id)
NZ (1) NZ508194A (id)
OA (1) OA11512A (id)
PL (1) PL193294B1 (id)
RO (1) RO121674B1 (id)
RU (1) RU2197227C2 (id)
SK (1) SK284890B6 (id)
TN (1) TNSN99097A1 (id)
TR (1) TR200003373T2 (id)
UA (1) UA69413C2 (id)
WO (1) WO1999061002A1 (id)
ZA (1) ZA993090B (id)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
JP2002507399A (ja) 1998-03-23 2002-03-12 ゼネラル ミルズ インコーポレイテッド 可食性製品への成分のカプセル化
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
AU2002219071A1 (en) * 2000-11-10 2002-05-21 F.Hoffman-La Roche Ag Compositions containing hydrolytically unstable compositions
DE60226965D1 (de) * 2001-04-04 2008-07-17 Ngk Insulators Ltd Vorrichtung zur regenwasserbehandlung in mischwasserkanälen und zugehöriges verfahren für die rückspülung
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
JP2005508326A (ja) * 2001-09-28 2005-03-31 マクニール−ピーピーシー・インコーポレイテッド 改質した放出用の投薬形態
WO2003057195A1 (en) * 2002-01-11 2003-07-17 Athpharma Limited Pravastatin pharmaceutical formulations and methods of their use
EP1905431A1 (en) * 2002-01-11 2008-04-02 Circ Pharma Research and Development Limited Pravastatin pharmaceutical formulations and methods of their use
EP2543385A1 (en) * 2002-01-21 2013-01-09 NRL Pharma, Inc. Novel analgesics
US20050089572A1 (en) * 2002-03-22 2005-04-28 Manoj Kumar Controlled release drug delivery system of pravastatin
US20040028737A1 (en) * 2002-08-12 2004-02-12 Kopran Research Laboratories Limited Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
AU2003263556A1 (en) * 2002-09-03 2004-03-29 Circ Pharma Research And Development Limited Pharmaceuticals formulations and methods for modified release of statin drugs
JP2006504686A (ja) * 2002-09-03 2006-02-09 バイオヴェイル ラボラトリーズ インコーポレイテッド プラバスタチンの医薬品製剤およびそれらの使用方法
MXPA05010636A (es) * 2003-04-04 2005-12-12 Pharmacia Corp Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
CN100415211C (zh) * 2003-07-03 2008-09-03 上海现代药物制剂工程研究中心 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法
MXPA06006586A (es) * 2003-12-09 2007-02-21 Pharmasset Inc Metodos de dosificacion para la terapia antiviral con beta-d-2',3'-didesoxi-2',3'-dideshidro-5-fluorocitidina.
DE602005009677D1 (de) * 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
US20050281876A1 (en) * 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
DE602005007376D1 (de) * 2004-11-18 2008-07-17 Bristol Myers Squibb Co Magensaftresistent beschichtetes pellet mit ixabepilon
EP1824458A1 (en) * 2004-11-18 2007-08-29 Bristol-Myers Squibb Company Enteric coated bead comprising epothilone or an epothilone analog, and preparation and administration thereof
WO2006054175A2 (en) * 2004-11-18 2006-05-26 Aurobindo Pharma Limited Stable dosage forms of acid labile drug
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CN101233229B (zh) 2005-07-29 2013-05-01 雅培实验室有限公司 制备消毒的胰酶粉末的方法
ES2560240T5 (es) 2005-07-29 2022-11-08 Stichting Groningen Centre For Drug Res Sistema de suministro pulsátil controlado por pH, métodos para la preparación y uso del mismo
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
PL1931316T5 (pl) 2005-08-15 2017-10-31 Abbott Laboratories Gmbh Kompozycje farmaceutyczne o kontrolowanym uwalnianiu dla leków labilnych kwasowo
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007072060A2 (en) * 2005-12-23 2007-06-28 Cipla Limited Particles comprising a core containing a hmg-coa reductase inhibitor and coated with a film
BRPI0707277B1 (pt) 2006-01-27 2021-07-13 The Regents Of The University Of California Composição, uso da mesma,e , formulação famacêutica
EP2012751A4 (en) 2006-03-21 2010-11-24 Morehouse School Of Medicine NEW NANOPARTICLES FOR THE DELIVERY OF ACTIVE AGENTS
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
ES2331501B1 (es) * 2007-11-14 2010-10-21 Blanver Farmoquimica, Ltda Composicion farmaceutica solida de didanosina.
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
DK2276485T3 (da) 2008-04-24 2014-10-13 Bristol Myers Squibb Co Anvendelse af epothilon d i behandling af tau-associerede sygdomme,herunder alzheimers sygdom
WO2010065751A2 (en) * 2008-12-03 2010-06-10 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase c agonists and methods of use
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
EP2621509A4 (en) 2010-09-15 2016-08-03 Synergy Pharmaceuticals Inc PREPARATIONS OF GUANYLATE CYCLASE-C AGONISTS AND METHODS OF USE
GB2484929A (en) 2010-10-25 2012-05-02 Maria Christiana Peter Geraedts An edible product including plant protein
KR20120135063A (ko) * 2011-06-01 2012-12-12 닛토덴코 가부시키가이샤 입자 제제 및 그 제조 방법
US10117447B1 (en) * 2013-03-15 2018-11-06 The United States Of America, As Represented By The Secretary Of Agriculture Extrusion of high density hydroxypropylmethylcellulose edible flexible gels
AR096628A1 (es) * 2013-06-17 2016-01-20 Raptor Pharmaceuticals Inc Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella
CN104758180A (zh) * 2014-01-06 2015-07-08 山东诚创医药技术开发有限公司 一种复方制剂胶囊的二次填充方法
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN109562137A (zh) 2015-09-01 2019-04-02 第波生物公司 用于治疗与异常炎性反应有关的病况的方法和组合物
US10143665B2 (en) 2015-11-17 2018-12-04 Horizon Orphan Llc Methods for storing cysteamine formulations and related methods of treatment
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
RU2670447C2 (ru) * 2016-11-17 2018-10-23 Общество с ограниченной ответственностью "Изварино Фарма" Пероральная твердая лекарственная форма с микофенольной кислотой или ее солью для использования в качестве иммунодепрессанта для лечения или предупреждения отторжения трансплантата органа или ткани и способ ее получения
WO2018218211A1 (en) 2017-05-26 2018-11-29 Animal Microbiome Analytics, Inc. Products and methods for therapeutic administration of microorganisms to non-human animals
KR20210043779A (ko) * 2019-10-11 2021-04-22 넨시스(주) 판크레아틴 장용코팅 펠릿 제조방법
WO2021142238A1 (en) 2020-01-10 2021-07-15 First Wave Bio, Inc. Deuterated niclosamide
TW202200121A (zh) 2020-03-16 2022-01-01 美商費斯特威弗生技股份有限公司 治療方法
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809918A (en) 1955-10-17 1957-10-15 Victor M Hermelin Sustained release pharmaceutical preparations
DE2010416B2 (de) 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
ZA822995B (en) 1981-05-21 1983-12-28 Wyeth John & Brother Ltd Slow release pharmaceutical composition
US4556552A (en) 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
US4704295A (en) 1983-09-19 1987-11-03 Colorcon, Inc. Enteric film-coating compositions
US4728512A (en) 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
AU570853B2 (en) 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
US5254539A (en) 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
US4975283A (en) 1985-12-12 1990-12-04 Bristol-Myers Squibb Company Stabilized enteric coated aspirin granules and process for preparation
US4775536A (en) 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US4794001A (en) 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
WO1988002629A1 (en) * 1986-10-16 1988-04-21 American Health Products Corporation 2',3'-didesoxyadenosine composition
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat
US4808413A (en) 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
JP2643222B2 (ja) 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US4925675A (en) 1988-08-19 1990-05-15 Himedics, Inc. Erythromycin microencapsulated granules
US5026559A (en) 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
CA2030581C (en) * 1989-11-24 2000-06-27 Gunther Atzl Pancreatin preparations
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US5175003A (en) 1990-04-06 1992-12-29 Biosytes Usa, Inc. Dual mechanism controlled release system for drug dosage forms
US5556839A (en) * 1991-04-29 1996-09-17 Eli Lilly And Company Form II Dirithromycin
HU9202318D0 (en) * 1991-07-22 1992-10-28 Bristol Myers Squibb Co Method for preparing medical preparatives containing didesoxi-purine nucleoside
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5350584A (en) 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
CA2141582C (en) 1992-08-05 2003-09-30 Angelo Mario Morella Pelletised pharmaceutical composition
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
IT1265074B1 (it) * 1993-05-18 1996-10-30 Istituto Biochimico Italiano Composizione farmaceutica a lento rilascio contenente come sostanza attiva un acido biliare
US5536507A (en) 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
EP0689840A1 (de) * 1994-06-28 1996-01-03 Spirig Ag Pharmazeutische Präparate Neues orales Erythromycinbase enthaltendes Arzneimittel
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5686106A (en) 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
US5789014A (en) 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I

Also Published As

Publication number Publication date
EP1079809A1 (en) 2001-03-07
NO322903B1 (no) 2006-12-18
US20010005716A1 (en) 2001-06-28
US6224910B1 (en) 2001-05-01
IL139274A0 (en) 2001-11-25
TR200003373T2 (tr) 2001-03-21
DZ2797A1 (fr) 2003-12-01
JP3798625B2 (ja) 2006-07-19
SK16302000A3 (sk) 2001-08-06
DK200200229U3 (da) 2003-01-24
AR017747A1 (es) 2001-10-24
DK1079809T3 (da) 2006-02-20
HUP0101714A2 (hu) 2002-01-28
ATE311859T1 (de) 2005-12-15
RU2197227C2 (ru) 2003-01-27
EE200000680A (et) 2002-10-15
LV12602A (en) 2001-01-20
HU226491B1 (en) 2009-03-02
DE69832731D1 (de) 2006-01-12
LT4843B (lt) 2001-09-25
BG65398B1 (bg) 2008-06-30
BR9815861A (pt) 2001-01-16
EE04926B1 (et) 2007-12-17
CN1149075C (zh) 2004-05-12
LT2000105A (en) 2001-04-25
CA2332922A1 (en) 1999-12-02
CA2332922C (en) 2008-02-12
OA11512A (en) 2004-02-03
NO20005879D0 (no) 2000-11-21
AT6311U1 (de) 2003-08-25
KR20010043736A (ko) 2001-05-25
ES2165833T1 (es) 2002-04-01
BG105061A (en) 2001-07-31
LV12602B (en) 2001-07-20
MA26636A1 (fr) 2004-12-20
EP1079809B1 (en) 2005-12-07
CN1294509A (zh) 2001-05-09
GEP20033014B (en) 2003-07-25
JP2006022115A (ja) 2006-01-26
TNSN99097A1 (fr) 2005-11-10
KR100484299B1 (ko) 2005-04-20
EP1079809A4 (en) 2001-11-07
NO20062106L (no) 1999-11-23
ES2165833T3 (es) 2006-05-16
JP2002516268A (ja) 2002-06-04
PL344259A1 (en) 2001-10-22
CO5070679A1 (es) 2001-08-28
AP2000001988A0 (en) 2000-12-31
CY1119543T1 (el) 2018-04-04
PL193294B1 (pl) 2007-01-31
CZ300497B6 (cs) 2009-06-03
CZ20004362A3 (en) 2001-05-16
AP1206A (en) 2003-09-18
HUP0101714A3 (en) 2002-10-28
IL139274A (en) 2004-12-15
SK284890B6 (sk) 2006-02-02
NO20005879L (no) 2001-01-18
UA69413C2 (uk) 2004-09-15
WO1999061002A1 (en) 1999-12-02
NZ508194A (en) 2003-07-25
DE1079809T1 (de) 2002-08-22
AU8685498A (en) 1999-12-13
ZA993090B (en) 2000-11-06
DE69832731T2 (de) 2006-09-14
AU750911B2 (en) 2002-08-01
RO121674B1 (ro) 2008-02-28
HK1034461A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
ID27031A (id) Komposisi farmasi bersalut enterik dan metode pembuatannya
BR9708624A (pt) Composições farmacéuticas revestidas e entéricas de micofenolato
ID27859A (id) Tampon dan metoda pembuatannya
LV12638A (lv) Enteric coated pharmaceutical tablet and method of manufacturing
EE9900454A (et) Varjestuskest ja varjestuskesta valmistamismeetod
PT1039909E (pt) Metodo de producao e composicao de uma preparacao oral de itraconazole
ID27093A (id) Lembaran komposit dan metode pembuatannya
ID30318A (id) Bahan-bahan dan metoda untuk modifikasi kandungan lignin tanaman
ID23638A (id) Metode pembuatan ekstrak artemisia farmasi dan peralatan untuk moksibusi listik menggunakan ekstrak tersebut
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
ID19385A (id) Adesif termosetting dan metoda pembuatannya
ID28025A (id) Metode pembuatan aminonitril dan diamina
ID18244A (id) Komposisi polipropilena dan metoda pembuatannya dan katalis untuk
EE04768B1 (et) Esmapakend ja meetod selle valmistamiseks
ID27255A (id) Lampu berbentuk lampu pijar dan metoda pembuatannya
EE200200105A (et) Radiofarmatseutilised saadused ja nende valmistamise meetod
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE04154B1 (et) Omeprasooli valmistamise meetod
DE69937596D1 (de) Verbinder und dessen Herstellungsverfahren
ID17769A (id) Kemasan dan metode pembuatannya
ID24590A (id) Metode dan komposisi untuk pembuatan lensa oftalmil berwarna
ID22367A (id) Lampu dan metoda pembuatannya
ID23527A (id) Sanyawa dan metoda pembuatan asam 4-fenil-4-sianosiklo-heksanoat tersubstitusi
ID25738A (id) Kolektor dan metode pembuatannya
ID25767A (id) Proses pembuatan asam-asam karboksilat kuinolon dan naftiridon